Effect of Non-invasive Magnetic Stimulation of the Brain on Breathlessness in Healthy Individuals.

NCT ID: NCT05623696

Last Updated: 2022-11-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-02-01

Study Completion Date

2023-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to see if the front part of the brain called the "Dorsolateral Prefrontal Cortex" (DLPFC) has a role in our ability to feel breathlessness. The experiment will use a device that sits on the top of the head which produces a magnetic field that penetrates the scalp and excites the brain tissue directly under it. This procedure is called repetitive transcranial magnetic stimulation (rTMS), it is a painless procedure and known to be safe in healthy individuals. Previous research has shown that the pain felt when capsaicin, the active ingredient in 'chilli' powder, is applied to the hand is reduced by applying the rTMS on the scalp directly above the DLPFC part of the brain. In this experiment we want to see if breathlessness is also reduced. We will use a breathing task that will generate a moderate amount of breathlessness by adding a small amount of carbon dioxide to the inhaled air, while preventing the increase in the amount of breathing we would normally see in response to this. If we find that breathlessness produced by this breathing task is reduced after rTMS over the DLPFC, this may lead to new drugs that target this part of the brain in patients suffering from breathlessness due to heart or lung disease. The study will also improve our knowledge of how the brain enables us to feel breathlessness

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dyspnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Following a practice session, there will be 3 intervention arms presented in random order on 3 separate days. The three arms will be: (i) 10-20mins of 5Hz rTMS over left DLPFC (Arm 1), (ii) 5Hz rTMS over right DLPFC (Arm 2), (iii) sham rTMS (Arm 3). A standard steady state air hunger test will be conducted before and immediately after each intervention.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants
Masking will only be applied to the participants in relation to whether they receive sham or actual rTMS.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stimulation of Left DLPFC

Intervention applied to Left DLPFC located by the BeamF3 technique

Group Type EXPERIMENTAL

Sham or actual non-invasive (Magnetic) brain stimulation

Intervention Type DEVICE

5 Hz rTMS applied using an actual or sham coil over the left or right DLPFC

Stimulation of Right DLPFC

Intervention applied to Right DLPFC located by the BeamF3 technique

Group Type ACTIVE_COMPARATOR

Sham or actual non-invasive (Magnetic) brain stimulation

Intervention Type DEVICE

5 Hz rTMS applied using an actual or sham coil over the left or right DLPFC

Sham Stimulation

Sham intervention applied to either the left or right DLPFC

Group Type SHAM_COMPARATOR

Sham or actual non-invasive (Magnetic) brain stimulation

Intervention Type DEVICE

5 Hz rTMS applied using an actual or sham coil over the left or right DLPFC

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sham or actual non-invasive (Magnetic) brain stimulation

5 Hz rTMS applied using an actual or sham coil over the left or right DLPFC

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MagStim

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

healthy individuals, over 18 years old, with no history of heart, lung or neurological conditions

Exclusion Criteria

* Any history of respiratory problems (including Asthma that involves regular use of inhalers)
* Any history of heart or circulatory problems (e.g. palpitations, arrhythmias, angina, BP)
* Any history of epilepsy, convulsions or seizures, migraines, or fainting
* Any history of anxiety disorders (e.g. panic attacks)
* Any history of serious head injury or brain surgery
* Any metal parts in the head (except dental wire)
* Any implants (e.g. pacemaker, insulin pump, neurostimulator)
* Pregnancy or problems with alcohol or drug abuse.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Oxford

OTHER

Sponsor Role collaborator

Oxford Brookes University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Shakeeb H Moosavi

Reader in Clinical Physiology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shakeeb H Moosavi, PhD

Role: PRINCIPAL_INVESTIGATOR

Oxford Brookes University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oxford Brookes University

Oxford, Oxfordshire, United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Shakeeb H Moosavi, PhD

Role: CONTACT

+44 (0)7834 083125

Sanjay Kumar, PhD

Role: CONTACT

+44 (0)1865 483768 ext. 3768

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Shakeeb H Moosavi, PhD

Role: primary

+44 (0)1865 4823257 ext. 3257

References

Explore related publications, articles, or registry entries linked to this study.

Banzett RB, Moosavi SH. Dyspnea and pain: Similarities and contrasts between two very unpleasant sensations. APS Bulletin. 2001; 11: 1-8.

Reference Type BACKGROUND

Brighina F, De Tommaso M, Giglia F, Scalia S, Cosentino G, Puma A, Panetta M, Giglia G, Fierro B. Modulation of pain perception by transcranial magnetic stimulation of left prefrontal cortex. J Headache Pain. 2011 Apr;12(2):185-91. doi: 10.1007/s10194-011-0322-8. Epub 2011 Feb 25.

Reference Type BACKGROUND
PMID: 21350791 (View on PubMed)

Harrison OK, Hayen A, Wager TD, Pattinson KTS. Investigating the specificity of the neurologic pain signature against breathlessness and finger opposition. Pain. 2021 Dec 1;162(12):2933-2944. doi: 10.1097/j.pain.0000000000002327.

Reference Type BACKGROUND
PMID: 33990110 (View on PubMed)

Herigstad M, Hayen A, Evans E, Hardinge FM, Davies RJ, Wiech K, Pattinson KTS. Dyspnea-related cues engage the prefrontal cortex: evidence from functional brain imaging in COPD. Chest. 2015 Oct;148(4):953-961. doi: 10.1378/chest.15-0416.

Reference Type BACKGROUND
PMID: 26134891 (View on PubMed)

Nierat MC, Hudson AL, Chaskalovic J, Similowski T, Laviolette L. Repetitive transcranial magnetic stimulation over the supplementary motor area modifies breathing pattern in response to inspiratory loading in normal humans. Front Physiol. 2015 Sep 29;6:273. doi: 10.3389/fphys.2015.00273. eCollection 2015.

Reference Type BACKGROUND
PMID: 26483701 (View on PubMed)

Yorke J, Moosavi SH, Shuldham C, Jones PW. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax. 2010 Jan;65(1):21-6. doi: 10.1136/thx.2009.118521. Epub 2009 Dec 8.

Reference Type BACKGROUND
PMID: 19996336 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HLS/2021/PH/002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effects of PrTMS on Performance
NCT05353244 WITHDRAWN NA